10.39
Precedente Chiudi:
$10.11
Aprire:
$10.2
Volume 24 ore:
891.99K
Relative Volume:
0.72
Capitalizzazione di mercato:
$461.13M
Reddito:
$100.25M
Utile/perdita netta:
$-73.20M
Rapporto P/E:
-6.1867
EPS:
-1.6794
Flusso di cassa netto:
$-56.22M
1 W Prestazione:
-2.07%
1M Prestazione:
-25.47%
6M Prestazione:
-60.66%
1 anno Prestazione:
-26.00%
Beta Bionics Inc Stock (BBNX) Company Profile
Nome
Beta Bionics Inc
Settore
Industria
Telefono
949-427-7785
Indirizzo
11 HUGHES, IRVINE
Compare BBNX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BBNX
Beta Bionics Inc
|
10.39 | 461.13M | 100.25M | -73.20M | -56.22M | -1.6794 |
|
ABT
Abbott Laboratories
|
108.03 | 187.72B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 128.88B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 102.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 47.52B | 6.07B | 1.06B | 1.34B | 1.8063 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-09 | Iniziato | UBS | Buy |
| 2026-01-27 | Iniziato | TD Cowen | Hold |
| 2026-01-09 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-10-21 | Ripresa | Stifel | Buy |
| 2025-10-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-06-16 | Iniziato | Truist | Buy |
| 2025-06-12 | Iniziato | Lake Street | Buy |
| 2025-05-30 | Iniziato | Goldman | Neutral |
| 2025-05-30 | Iniziato | Wolfe Research | Outperform |
| 2025-02-24 | Iniziato | BofA Securities | Buy |
| 2025-02-24 | Iniziato | Lake Street | Buy |
| 2025-02-24 | Iniziato | Leerink Partners | Outperform |
| 2025-02-24 | Iniziato | Piper Sandler | Overweight |
| 2025-02-24 | Iniziato | Stifel | Buy |
| 2025-02-20 | Iniziato | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Iniziato | Robert W. Baird | Neutral |
Mostra tutto
Beta Bionics Inc Borsa (BBNX) Ultime notizie
Beta BionicsSpeculative Appeal After An Eventful Start To The Year (NASDAQ:BBNX) - Seeking Alpha
Risk Check: How cyclical is Beta Bionics Incs revenue streamM&A Rumor & Fast Gain Stock Tips - baoquankhu1.vn
BBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics - GlobeNewswire
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - The Malaysian Reserve
Fed Watch: Does Beta Bionics Inc have pricing power2026 Institutional & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
BBNX,LYRA Volatility & Greeks - Finviz
Beta Bionics Earnings Call Signals Growth and Investment - TipRanks
BBNX Stock May Gain From Abbott Deal to Advance iLet Integration - MSN
Will Beta Bionics Inc. stock deliver consistent dividends2025 Historical Comparison & Free Fast Entry Momentum Trade Alerts - Naître et grandir
Trade Recap: Why is Beta Bionics Inc stock going downWeekly Market Report & High Yield Equity Trading Tips - baoquankhu1.vn
BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics - 巴士的報
Beta Bionics Details iLet Automation Strategy, Sales Expansion and Mint Patch Pump Timeline at Conference - Yahoo Finance
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - Sahm
Beta Bionics, Inc. (NASDAQ:BBNX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Insider Sell: Mark Hopman Sells Shares of Beta Bionics Inc (BBNX) - GuruFocus
Hopman, Beta Bionics CCO, sells $4k in BBNX stock By Investing.com - Investing.com Canada
Hopman, Beta Bionics CCO, sells $4k in BBNX stock - Investing.com UK
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus
Beta Bionics, Inc. $BBNX Position Boosted by Pura Vida Investments LLC - MarketBeat
First Eagle Investment Management LLC Buys Shares of 233,202 Beta Bionics, Inc. $BBNX - MarketBeat
Aug Technicals: Can Beta Bionics Inc deliver alphaM&A Rumor & Long-Term Safe Investment Plans - baoquankhu1.vn
[144] Beta Bionics, Inc. SEC Filing - Stock Titan
Stephen Feider files Form 144 to sell BBNX common stock (BBNX) - Stock Titan
Sean Saint to sell 3,384 Beta Bionics shares (BBNX) via Morgan Stanley - Stock Titan
Beta Bionics Receives Warning Letter from U.S. Department of Health and Human Services Food and Drug Administration Center - marketscreener.com
Medtronic Diabetes Unit MiniMed’s IPO Sparks Analyst Debate - Bloomberg.com
BBNX Earnings History & Surprises | EPS & Revenue Results | BETA BIONICS INC (NASDAQ:BBNX) - ChartMill
BBNX: iLet’s automation and Mint patch pump drive growth as pharmacy models reshape the market - TradingView
Beta Bionics Insider Sells $10,308 in Stock - National Today
Beta Bionics insider sells $13,151 in stock - National Today
BBNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Beta Bionics Insiders Quietly Cash Out in a Wave of Executive Stock Sales - TipRanks
Beta Bionics (NASDAQ:BBNX) Insider Steven Jon Russell Sells 1,026 Shares - MarketBeat
Beta Bionics (NASDAQ:BBNX) CFO Sells $17,650.08 in Stock - MarketBeat
Mike Mensinger Sells 1,064 Shares of Beta Bionics (NASDAQ:BBNX) Stock - MarketBeat
Insider Selling: Beta Bionics (NASDAQ:BBNX) Insider Sells 834 Shares of Stock - MarketBeat
BBNX SEC FilingsBeta Bionics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Beta Bionics (BBNX) CCO gets equity awards, sells shares for taxes - Stock Titan
Beta Bionics (BBNX) CMO sells shares, receives RSU and option awards - Stock Titan
BBNX CPO Mike Mensinger reports equity grants, tax-related sale in Form 4 - Stock Titan
[Form 4] Beta Bionics, Inc. Insider Trading Activity - Stock Titan
BBNX CEO Sean Saint gets major equity awards and small tax-related share sale - Stock Titan
BBNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors ... - Bluefield Daily Telegraph
BBNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - Nasdaq
BBNX.O PE Ratio & Valuation, Is BBNX.O Overvalued - Intellectia AI
BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus
BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - Financial Times
Beta Bionics, Inc. (BBNX) Stock Analysis: Exploring a Potential 79.85% Upside in Healthcare Innovation - DirectorsTalk Interviews
FDA warns Beta Bionics on unreported complaints, insulin pump changes - MedTech Dive
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - Nasdaq
Beta Bionics, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow ... - Bluefield Daily Telegraph
Beta Bionics Inc Azioni (BBNX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):